Reactivity of the BV2⁺ and BV8S3⁺ T-cell clones with malignant cells from patients with other hematologic malignancies. Proliferation of the BV2⁺ T-cell clones 4F10 and 1F2 (A) and the BV8S3⁺ T-cell clone (B) in response to malignant cell samples and normal cell samples from HLA-DR4DQ3⁺DPB1*04⁺ patients with CLL, NHL, ALL, CML, AML, and healthy individuals, respectively.